ALISKIREN HEMIFUMARATE | Marketing Authorisations | MA | Europe | PharmaCompass.com

Please Wait

Applying Filters...

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
NEW Find Prospects
- Prospector
Drugs in Dev.
News
Blog
Market Place
Login

ALISKIREN HEMIFUMARATE
Europe

ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

Contact Supplier

Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.

Contact Supplier

pharmacompass-1-m-2026-01-12

LEBSA- Your strategic API source for niche molecules.

Contact Supplier

Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

Contact Supplier

pharmacompass-2-m-2025-11-03

ALISKIREN HEMIFUMARATE

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

9 API Suppliers, 4 USDMF, 1 EU WC, 3 NDC API, 4 Listed Suppliers

9 API Suppliers
4 USDMF
1 EU WC
3 NDC API
4 Listed Suppliers

DEVELOPMENTS

31 Drugs in Development

31 Drugs in Development

INTERMEDIATES

5 Intermediate Suppliers

5 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

49 FDF Dossiers, 20 FDA Orange Book, 29 Europe

49 FDF Dossiers
20 FDA Orange Book
29 Europe

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - EQ 150MG BASE, TABLET;ORAL - EQ 300MG BASE, TABLET;ORAL - EQ 150MG BASE;12.5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - EQ 150MG BASE;25MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - EQ 300MG BASE;12.5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - EQ 300MG BASE;25MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET;ORAL - EQ 150MG BASE
TABLET;ORAL - EQ 300MG BASE
TABLET;ORAL - EQ 150MG BASE;12.5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET;ORAL - EQ 150MG BASE;25MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET;ORAL - EQ 300MG BASE;12.5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET;ORAL - EQ 300MG BASE;25MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

1 SPI Pharma, 6 DKSH, 5 Boai NKY Pharmaceuticals Ltd, 2 Gangwal Healthcare, 1 ACG Worldwide, 3 Actylis, 1 Aeon Procare, 1 Alcedo Pharmachem, 5 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 2 Ashland, 22 BASF, 10 Corel Pharma Chem, 2 DFE Pharma, 1 Esteem Industries, 1 Finar, 8 Gangwal Chemicals, 4 Ideal Cures, 11 Kerry, 1 Keval Exports, 3 Kima Chemical, 6 Lonza Capsugel, 10 Microlex e.U, 2 Nitika Pharmaceutical Specialities, 2 Nomisma Healthcare, 3 Novo Excipients, 3 Pharmatrans-Sanaq, 2 Pluviaendo, 2 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 1 Qualicaps, 10 Roquette, 6 Seppic, 3 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 9 Sigachi Industries, 2 Silverline Chemicals, 2 The Dow Chemical Company, 1 Ulanqab Kema New Material, 2 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

40 Coating Systems & Additives, 32 Fillers, Diluents & Binders, 22 Controlled & Modified Release, 19 Thickeners and Stabilizers, 18 Disintegrants & Superdisintegrants, 18 Direct Compression, 17 Granulation, 13 Solubilizers, 12 Lubricants & Glidants, 8 Co-Processed Excipients, 8 Topical, 8 Chewable & Orodispersible Aids, 7 Film Formers & Plasticizers, 5 Empty Capsules, 5 Coloring Agents, 4 Vegetarian Capsules, 4 API Stability Enhancers, 4 Taste Masking, 4 Emulsifying Agents, 4 Rheology Modifiers, 2 Parenteral

40 Coating Systems & Additives
32 Fillers, Diluents & Binders
22 Controlled & Modified Release
19 Thickeners and Stabilizers
18 Disintegrants & Superdisintegrants
18 Direct Compression
17 Granulation
13 Solubilizers
12 Lubricants & Glidants
8 Co-Processed Excipients
8 Topical
8 Chewable & Orodispersible Aids
7 Film Formers & Plasticizers
5 Empty Capsules
5 Coloring Agents
4 Vegetarian Capsules
4 API Stability Enhancers
4 Taste Masking
4 Emulsifying Agents
4 Rheology Modifiers
2 Parenteral

DIGITAL CONTENT

13 News #PharmaBuzz

13 News #PharmaBuzz

GLOBAL SALES INFORMATION

4 US Medicaid Prescriptions, 1 Annual Reports

4 US Medicaid Prescriptions
1 Annual Reports

MARKET PLACE

1 APIs, 1 FDF Dossiers

1 APIs
1 FDF Dossiers

PATENTS & EXCLUSIVITIES

14 US Patents, 10 Health Canada Patents

14 US Patents
10 Health Canada Patents

Xls

Filters

Reset all filters

Filters

FILTER :

filter Applicant Reset all filters

29 All

01 2Future Health Pharma Gmbh

02 14Noden Pharma Designated Activity Company

03 1Novartis Europharm Limited

04 8Novartis Europharm Ltd

05 2The Pharma DAC node

06 2The Pharma Dac Node

filter Active Ingredients Reset all filters

29 All

01 4Aliskiren

02 10Aliskiren Hemifumarate

03 2Aliskiren hemifumarate

04 9Aliskireno

05 4Hydrochlorothiazide; Aliskirene

filter Dosage Form Reset all filters

29 All

01 27Film Coated Tablet

02 2Film-Coated Tablet

filter Country Reset all filters

29 All

01 2Estonia

02 2Norway

03 13Spain

04 10Sweden

05 2Switzerland

filter Brand Name Reset all filters

29 All

01 2Enviage

02 17Rasilez

03 4Rasilez Hct

04 2Riprazo

05 2Sprimeo

06 2Tekturna

List of Suppliers

Product Main Page

01

The Pharma Dac Node

IPPE

Not Confirmed

The Pharma Dac Node

IPPE

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info : Approved

Registration Country : Sweden

Aliskiren Hemifumarate

Brand Name : Rasilez

Dosage Form : Film Coated Tablet

Dosage Strength : 150mg

Packaging :

Approval Date : 22/08/2007

Application Number : 20061009000013

Regulatory Info : Approved

Registration Country : Sweden

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

02

The Pharma Dac Node

IPPE

Not Confirmed

The Pharma Dac Node

IPPE

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info : Approved

Registration Country : Sweden

Aliskiren Hemifumarate

Brand Name : Rasilez

Dosage Form : Film Coated Tablet

Dosage Strength : 300mg

Packaging :

Approval Date : 22/08/2007

Application Number : 20061009000020

Regulatory Info : Approved

Registration Country : Sweden

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

03

Novartis Europharm Ltd

IPPE

Not Confirmed

Novartis Europharm Ltd

IPPE

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info : Deregistered

Registration Country : Sweden

Aliskiren Hemifumarate

Brand Name : Enviage

Dosage Form : Film Coated Tablet

Dosage Strength : 150mg

Packaging :

Approval Date : 22/08/2007

Application Number : 20070411000023

Regulatory Info : Deregistered

Registration Country : Sweden

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

04

Novartis Europharm Ltd

IPPE

Not Confirmed

Novartis Europharm Ltd

IPPE

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info : Deregistered

Registration Country : Sweden

Aliskiren Hemifumarate

Brand Name : Enviage

Dosage Form : Film Coated Tablet

Dosage Strength : 300mg

Packaging :

Approval Date : 22/08/2007

Application Number : 20070411000030

Regulatory Info : Deregistered

Registration Country : Sweden

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

05

Novartis Europharm Ltd

IPPE

Not Confirmed

Novartis Europharm Ltd

IPPE

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info : Deregistered

Registration Country : Sweden

Aliskiren Hemifumarate

Brand Name : Riprazo

Dosage Form : Film Coated Tablet

Dosage Strength : 150mg

Packaging :

Approval Date : 22/08/2007

Application Number : 20070411000047

Regulatory Info : Deregistered

Registration Country : Sweden

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

06

Novartis Europharm Ltd

IPPE

Not Confirmed

Novartis Europharm Ltd

IPPE

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info : Deregistered

Registration Country : Sweden

Aliskiren Hemifumarate

Brand Name : Riprazo

Dosage Form : Film Coated Tablet

Dosage Strength : 300mg

Packaging :

Approval Date : 22/08/2007

Application Number : 20070411000054

Regulatory Info : Deregistered

Registration Country : Sweden

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

07

Novartis Europharm Ltd

IPPE

Not Confirmed

Novartis Europharm Ltd

IPPE

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info : Deregistered

Registration Country : Sweden

Aliskiren Hemifumarate

Brand Name : Sprimeo

Dosage Form : Film Coated Tablet

Dosage Strength : 150mg

Packaging :

Approval Date : 22/08/2007

Application Number : 20070411000061

Regulatory Info : Deregistered

Registration Country : Sweden

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

08

Novartis Europharm Ltd

IPPE

Not Confirmed

Novartis Europharm Ltd

IPPE

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info : Deregistered

Registration Country : Sweden

Aliskiren Hemifumarate

Brand Name : Sprimeo

Dosage Form : Film Coated Tablet

Dosage Strength : 300mg

Packaging :

Approval Date : 22/08/2007

Application Number : 20070411000078

Regulatory Info : Deregistered

Registration Country : Sweden

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

09

Future Health Pharma Gmbh

Country

IPPE

Not Confirmed

Future Health Pharma Gmbh

Country

IPPE

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Country

Virtual Booth

Digital Content

Regulatory Info : Allowed

Registration Country : Switzerland

Brand Name : Rasilez

Dosage Form : Film Coated Tablet

Dosage Strength : 150mg

Packaging :

Approval Date : 29/06/2007

Application Number : 58050

Regulatory Info : Allowed

Registration Country : Switzerland

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

10

Future Health Pharma Gmbh

Country

IPPE

Not Confirmed

Future Health Pharma Gmbh

Country

IPPE

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Country

Virtual Booth

Digital Content

Regulatory Info : Allowed

Registration Country : Switzerland

Brand Name : Rasilez

Dosage Form : Film Coated Tablet

Dosage Strength : 300mg

Packaging :

Approval Date : 29/06/2007

Application Number : 58050

Regulatory Info : Allowed

Registration Country : Switzerland

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

1
2
3

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.